Skip to content

Zenith Renu G55406Recalls & reported problems

Cook Incorporated · Zenith Renu, AAA Ancillary Graft Main Body Extension · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002554068), received between Oct 10, 2017 and Oct 10, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Difficult or Delayed Positioning” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Difficult or Delayed Positioning1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 10, 2017Difficult or Delayed Positioning; Difficult or Delayed Positioning

    THE AREA REPRESENTATIVE REPORTED ATTENDING AN AORTIC ANEURYSM REPAIR OF AN ANGULATED POSTERIOR DIVING AORTA. AS REPORTED, WHEN THE PHYSICIAN WAS ATTEMPTING TO DEPLOY THE ZENITH RENU AAA ANCILLARY GRAFT MAIN BODY EXTENSION IT WAS VERY HARD TO PUSH UP THE TOP CAP. A SIGNIFICANT AMOUNT OF FORCE WAS NEEDED IN ORDER TO RELEASE THE SUPRARENAL STENTS. IN SPITE OF THE DIFFICULTY, THE PROCEDURE WAS COMPLETED SUCCESSFULLY. THERE WERE NO ADVERSE EFFECTS OR CONSEQUENCES TO THE PATIENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6937658 ↗

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page